cilostazol has been researched along with Carotid Artery Diseases in 11 studies
Carotid Artery Diseases: Pathological conditions involving the CAROTID ARTERIES, including the common, internal, and external carotid arteries. ATHEROSCLEROSIS and TRAUMA are relatively frequent causes of carotid artery pathology.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare prevention by cilostazol and aspirin of progression of atherosclerosis, we conducted a prospective, randomized, open, blinded end point study in 4 East Asian countries." | 9.14 | The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: principal results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) study: a randomized trial. ( Katakami, N; Kawamori, R; Kim, YS; Yamasaki, Y, 2010) |
| "9 years) with ischemic stroke or carotid artery stenting who received clopidogrel (75 mg) for >7 days at our hospital between October 2009 and March 2010." | 7.77 | Clopidogrel resistance and the effect of combination cilostazol in patients with ischemic stroke or carotid artery stenting using the VerifyNow P2Y12 Assay. ( Deguchi, I; Dembo, T; Fukuoka, T; Horiuchi, Y; Kato, Y; Maruyama, H; Nagoya, H; Takeda, H; Tanahashi, N, 2011) |
| "In the present study, cerebral ischemia was induced by a 10 min transient bilateral common carotid artery occlusion in rats combined with arterial blood pressure lowering to 37-42 mm Hg during occlusion." | 5.35 | Cilostazol preserves CA1 hippocampus and enhances generation of immature neuroblasts in dentate gyrus after transient forebrain ischemia in rats. ( Hong, KW; Kim, CD; Lee, JH; Lee, WS; Park, SY; Shin, HK, 2009) |
| " The PreventIon of CArdiovascular events in iSchemic Stroke patients with high risk of cerebral hemOrrhage-Intima-Media Thickness (PICASSO-IMT) sub-study is designed to investigate the effects of cilostazol, probucol, or both on IMT in patients with stroke." | 5.24 | Design and Rationale of the Intima-Medial Thickness Sub-Study of the PreventIon of CArdiovascular Events in iSchemic Stroke Patients with High Risk of Cerebral hemOrrhage (PICASSO-IMT) Study. ( Kim, YJ; Kwon, SU; Lee, J; Seo, WK, 2017) |
| "To compare prevention by cilostazol and aspirin of progression of atherosclerosis, we conducted a prospective, randomized, open, blinded end point study in 4 East Asian countries." | 5.14 | The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: principal results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) study: a randomized trial. ( Katakami, N; Kawamori, R; Kim, YS; Yamasaki, Y, 2010) |
| "9 years) with ischemic stroke or carotid artery stenting who received clopidogrel (75 mg) for >7 days at our hospital between October 2009 and March 2010." | 3.77 | Clopidogrel resistance and the effect of combination cilostazol in patients with ischemic stroke or carotid artery stenting using the VerifyNow P2Y12 Assay. ( Deguchi, I; Dembo, T; Fukuoka, T; Horiuchi, Y; Kato, Y; Maruyama, H; Nagoya, H; Takeda, H; Tanahashi, N, 2011) |
| "Cilostazol was associated with a significant reduction in the progression of carotid IMT (WMD, -0." | 2.48 | Effect of cilostazol on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials. ( Deng, J; Geng, DF; Jin, DM; Wang, JF; Wu, W, 2012) |
| "Sildenafil failed to prevent CCH-induced retrograde amnesia, but it reduced hippocampal cell death." | 1.42 | Cilostazol but not sildenafil prevents memory impairment after chronic cerebral hypoperfusion in middle-aged rats. ( Bacarin, CC; de Oliveira, JN; de Oliveira, RM; Ferreira, ED; Godinho, J; Milani, H; Zaghi, GG, 2015) |
| "Cilostazol is an antiplatelet agent that can induce the regression of atherosclerosis." | 1.40 | Carotid plaque characteristics on magnetic resonance plaque imaging following long-term cilostazol therapy. ( Narumi, S; Ohba, H; Oura, K; Sasaki, M; Terayama, Y; Uwano, I; Yamaguchi Oura, M, 2014) |
| "Cilostazol is a unique antiplatelet drug that has vasodilatory effects and inhibits smooth muscle cell proliferation." | 1.36 | Cilostazol reduces restenosis after carotid artery stenting. ( Hayakawa, M; Matsumaru, Y; Matsumura, A; Nemoto, S; Takigawa, T, 2010) |
| "In the present study, cerebral ischemia was induced by a 10 min transient bilateral common carotid artery occlusion in rats combined with arterial blood pressure lowering to 37-42 mm Hg during occlusion." | 1.35 | Cilostazol preserves CA1 hippocampus and enhances generation of immature neuroblasts in dentate gyrus after transient forebrain ischemia in rats. ( Hong, KW; Kim, CD; Lee, JH; Lee, WS; Park, SY; Shin, HK, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 10 (90.91) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seo, WK | 1 |
| Kim, YJ | 1 |
| Lee, J | 1 |
| Kwon, SU | 1 |
| Kim, SM | 1 |
| Cho, KI | 1 |
| Yamaguchi Oura, M | 1 |
| Sasaki, M | 1 |
| Ohba, H | 1 |
| Narumi, S | 1 |
| Oura, K | 1 |
| Uwano, I | 1 |
| Terayama, Y | 1 |
| Kwon, KJ | 1 |
| Lee, EJ | 1 |
| Kim, MK | 1 |
| Kim, SY | 1 |
| Kim, JN | 1 |
| Kim, JO | 1 |
| Kim, HJ | 1 |
| Kim, HY | 1 |
| Han, JS | 1 |
| Shin, CY | 1 |
| Han, SH | 1 |
| Godinho, J | 1 |
| de Oliveira, JN | 1 |
| Ferreira, ED | 1 |
| Zaghi, GG | 1 |
| Bacarin, CC | 1 |
| de Oliveira, RM | 1 |
| Milani, H | 1 |
| Lee, JH | 1 |
| Shin, HK | 1 |
| Park, SY | 1 |
| Kim, CD | 1 |
| Lee, WS | 1 |
| Hong, KW | 1 |
| Takigawa, T | 1 |
| Matsumaru, Y | 1 |
| Hayakawa, M | 1 |
| Nemoto, S | 1 |
| Matsumura, A | 1 |
| Katakami, N | 1 |
| Kim, YS | 1 |
| Kawamori, R | 1 |
| Yamasaki, Y | 1 |
| Maruyama, H | 1 |
| Takeda, H | 1 |
| Dembo, T | 1 |
| Nagoya, H | 1 |
| Kato, Y | 1 |
| Fukuoka, T | 1 |
| Deguchi, I | 1 |
| Horiuchi, Y | 1 |
| Tanahashi, N | 1 |
| Geng, DF | 1 |
| Deng, J | 1 |
| Jin, DM | 1 |
| Wu, W | 1 |
| Wang, JF | 1 |
| Takayama, K | 1 |
| Taoka, T | 1 |
| Nakagawa, H | 1 |
| Myouchin, K | 1 |
| Wada, T | 1 |
| Sakamoto, M | 1 |
| Furuichi, K | 1 |
| Iwasaki, S | 1 |
| Kurokawa, S | 1 |
| Kichikawa, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Cilostazol, a Phosphodiesterase 3 Inhibitor, on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes[NCT03248401] | Phase 4 | 50 participants (Actual) | Interventional | 2016-09-26 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for cilostazol and Carotid Artery Diseases
| Article | Year |
|---|---|
Effect of cilostazol on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials.
Topics: Aged; Carotid Artery Diseases; Carotid Intima-Media Thickness; Cilostazol; Disease Progression; Drug | 2012 |
2 trials available for cilostazol and Carotid Artery Diseases
| Article | Year |
|---|---|
Design and Rationale of the Intima-Medial Thickness Sub-Study of the PreventIon of CArdiovascular Events in iSchemic Stroke Patients with High Risk of Cerebral hemOrrhage (PICASSO-IMT) Study.
Topics: Brain Ischemia; Cardiovascular Agents; Carotid Artery Diseases; Carotid Artery, Common; Carotid Inti | 2017 |
The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: principal results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) study: a randomized trial.
Topics: Aged; Atherosclerosis; Carotid Artery Diseases; Cilostazol; Diabetes Mellitus, Type 2; Female; Human | 2010 |
8 other studies available for cilostazol and Carotid Artery Diseases
| Article | Year |
|---|---|
Impact of cilostazol on the progression of carotid atherosclerosis in patients with retinal vascular occlusion.
Topics: Adult; Aged; Aged, 80 and over; Carotid Artery Diseases; Carotid Intima-Media Thickness; Cilostazol; | 2013 |
Carotid plaque characteristics on magnetic resonance plaque imaging following long-term cilostazol therapy.
Topics: Aged; Carotid Artery Diseases; Cilostazol; Female; Fibrosis; Humans; Imaging, Three-Dimensional; Int | 2014 |
Diabetes augments cognitive dysfunction in chronic cerebral hypoperfusion by increasing neuronal cell death: implication of cilostazol for diabetes mellitus-induced dementia.
Topics: Animals; Brain; Brain-Derived Neurotrophic Factor; Carotid Artery Diseases; Caspase 3; Cell Death; C | 2015 |
Cilostazol but not sildenafil prevents memory impairment after chronic cerebral hypoperfusion in middle-aged rats.
Topics: Aging; Amnesia, Retrograde; Animals; Brain Ischemia; Carotid Artery Diseases; Carotid Artery, Intern | 2015 |
Cilostazol preserves CA1 hippocampus and enhances generation of immature neuroblasts in dentate gyrus after transient forebrain ischemia in rats.
Topics: Analysis of Variance; Animals; Brain Ischemia; Bromodeoxyuridine; Carotid Artery Diseases; Cell Surv | 2009 |
Cilostazol reduces restenosis after carotid artery stenting.
Topics: Aged; Angioplasty; Carotid Artery Diseases; Cilostazol; Drug Therapy, Combination; Female; Humans; M | 2010 |
Clopidogrel resistance and the effect of combination cilostazol in patients with ischemic stroke or carotid artery stenting using the VerifyNow P2Y12 Assay.
Topics: Aged; Blood Coagulation Tests; Blood Platelets; Carotid Artery Diseases; Cilostazol; Clopidogrel; Dr | 2011 |
Effect of cilostazol in preventing restenosis after carotid artery stenting using the carotid wallstent: a multicenter retrospective study.
Topics: Aged; Aged, 80 and over; Carotid Artery Diseases; Cilostazol; Female; Graft Occlusion, Vascular; Hum | 2012 |